搜索临床试验以:Relapsed/Refractory NHL
总计4905个结果
-
Arvinas Inc.招聘中复发/难治性 (R/R) 成熟 B 细胞非霍奇金淋巴瘤 (NHL) | 复发/难治性 (R/R) 血管免疫母细胞 T 细胞淋巴瘤 (AITL)美国, 西班牙
-
Atara Biotherapeutics招聘中高级别 B 细胞淋巴瘤 | MCL | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 复发/难治性 B 细胞非霍奇金淋巴瘤 | 伴有 MYC 和 BCL2 重排的 DLBCL/高级 B 细胞淋巴瘤 | 间变性淋巴瘤激酶阳性大 B 细胞淋巴瘤 | LBCL 与 IRF4 重排 | 11q 畸变的高级别 B 细胞淋巴瘤 | Epstein-Barr 病毒阳性 DLBCL | DLBCL 与慢性炎症相关 | 纤维蛋白相关LBCL | 原发性皮肤 DLBCL,腿型 | 血管内LBCL | 原发性纵隔LBCL | 源自转化性惰性淋巴瘤的 DLBCL | 纵隔灰区淋巴瘤 | 佛罗里达州 3B 级美国
-
Regeneron Pharmaceuticals招聘中B 细胞非霍奇金淋巴瘤 (B-NHL)台湾, 西班牙, 大韩民国, 泰国, 澳大利亚, 意大利, 马来西亚, 火鸡
-
Nektar Therapeutics招聘中
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan Hospital招聘中
-
The First Affiliated Hospital of Soochow UniversityWest China Hospital; Affiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower... 和其他合作者招聘中
-
The First Affiliated Hospital of Soochow University招聘中
-
Cullinan Therapeutics Inc.主动,不招人
-
M.D. Anderson Cancer Center完全的
-
Calithera Biosciences, Inc终止非 GCB/ABC 弥漫性大 B 细胞淋巴瘤 | 有无 MyD88 和/或 CD79B 突变美国
-
Menarini Group终止转移性实体瘤 | 复发/难治性非霍奇金淋巴瘤意大利, 西班牙, 比利时, 英国
-
Amgen完全的B细胞非霍奇金淋巴瘤美国, 西班牙, 英国, 比利时, 意大利, 澳大利亚, 加拿大, 波多黎各
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Ohio State University Comprehensive Cancer Center完全的
-
Janssen Research & Development, LLC招聘中
-
University of Colorado, BoulderNational Heart, Lung, and Blood Institute (NHLBI); Northwestern University招聘中
-
University of HawaiiNational Heart, Lung, and Blood Institute (NHLBI); National Association of Pasifika Organizations 和其他合作者尚未招聘高血压 | 2 型糖尿病 | 血脂异常 | 糖尿病前期 | 心脏代谢综合征 | 减肥试验美国
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
University of ArkansasNational Heart, Lung, and Blood Institute (NHLBI); University of Hawaii Cancer Research Center; Coalition for a Tobacco Free Arkansas尚未招聘水果和蔬菜消费
-
Rong TaoNovatim Immune Therapeutics (Zhejiang) Co., Ltd.招聘中
-
InSilico Medicine Hong Kong Limited招聘中
-
First Affiliated Hospital of Zhejiang UniversityCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.招聘中
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
Vittoria BiotherapeuticsUniversity of Pennsylvania尚未招聘
-
Peter MacCallum Cancer Centre, AustraliaAbbVie尚未招聘
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
Duke UniversityUniversity of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI)尚未招聘肺移植排斥反应 | 肺移植失败 | 肺移植;并发症 | 肺移植;感染或炎症
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI); University of Michigan; University of California... 和其他合作者招聘中
-
Dren BioNovotech (Australia) Pty Limited招聘中
-
University of Massachusetts, WorcesterNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)招聘中
-
University of California, San DiegoMayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham and Women... 和其他合作者招聘中
-
Boston Immune Technologies and Therapeutics尚未招聘外周T细胞淋巴瘤 | 非霍奇金淋巴瘤 | 皮肤T细胞淋巴瘤
-
Oregon State UniversityNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd; Suzhou Hongci Hematology Hospital,...招聘中
-
JHSPH Center for Clinical TrialsNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
LLS PedAL Initiative, LLCKura Oncology尚未招聘复发/难治性 KMT2A-r 急性白血病 | 复发/难治性 NUP98-r 急性白血病 | 复发/难治性 NPM1-m 急性白血病
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘疼痛 | 镰状细胞性贫血症
-
Peking University People's Hospital尚未招聘
-
St. Jude Children's Research HospitalNational Heart, Lung, and Blood Institute (NHLBI)招聘中